Stockreport

OptiNose granted FDA nod to expand labeling for sinusitis therapy [Seeking Alpha]

OptiNose, Inc.  (OPTN) 
Last optinose, inc. earnings: 3/5 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.optinose.com
PDF labeling for its lead product, Xhance, a drug-device combination indicated in the U.S. for chronic sinusitis. Accordingly, Xhance, designed to deliver a topical steroi [Read more]